While 2023 net revenue was 26% lower than that peak, as interest rates and economic uncertainty increased, the firm appears to have stabilized and looks poised for a return to high-single-digit ...
Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...
Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...
Analysts say NVIDIA (NASDAQ: NVDA) is a buy ahead of earnings because the results will be robust, high-double-digit growth is ...
Evercore ISI analyst David Palmer is adding Wendy’s (WEN) to the firm’s “Tactical Outperform List” as the firm sees upside heading into Wendy’s ...